Back to Results
First PageMeta Content
Dronedarone / Sulfonamides / Sanofi / Chemistry / Organic chemistry / Benzofurans


Initial REMS Approval: July 2009 Most Recent Modification: March 2014 NDA[removed]Multaq® (dronedarone) sanofi-aventis U.S. 55 Corporate Boulevard Bridgewater, New Jersey 08807
Add to Reading List

Open Document

File Size: 1,12 MB

Share Result on Facebook

City

Corporate Boulevard Bridgewater / Reference / /

Company

Sanofi / sanofi-aventis / /

Country

United States / /

Event

FDA Phase / /

Facility

American College of Cardiology / /

IndustryTerm

healthcare professionals / /

MedicalCondition

IV heart failure / hepatic failure II / permanent atrial fibrillation / Severe liver injury / heart failure / hepatic failure / atrial fibrillation / Symptomatic heart failure / liver injury / stroke / /

MedicalTreatment

counseling / /

Organization

Sponsor’s Medical Information Services Department / the American College / FDA / AF REMS / /

Product

Multaq® (dronedarone) / /

ProvinceOrState

New Jersey / /

URL

www.multaqrems.com / /

SocialTag